Startup française : "Un vaccin nasal français contre la COVID-19 bloquant toute contagiosité et efficace contre les variants"
Tours, France
Joined April 2023
- Tweets29
- Following57
- Followers30
- Likes9
Covid-19 : ces signes qui annoncent l’arrivée d’une nouvelle vague !
Plusieurs variants, un seul vaccin !
#unproblèmeunesolution #besafe #vaccin #COVID19 #variant #lovaltech
lexpress.fr/sciences-sante/s…
Patrick Barillot was invited to appear on @BFMTV's Good morning Business program to give an update on the development of the @LoValTechFR nasal vaccine.
#nasalvaccine #lovaltech #COVID19 #workinprogress
youtube.com/watch?v=4wE6TedW…
‘For the first time, we could be ahead of variants’
As detailed in this Maddyness article, this is one of the major advantages of our COVID-19 vaccine.
#nasalvaccine #lovatech #variants #article #DaVinciLabs #DeepTech #SynBio
maddyness.com/2023/08/23/lov…
Needle free vaccines start to come out from the labs!!!❌💉
Mathieu Epardaud brilliantly explains the interest of nasal vaccination !
To find out all about these French advances, don't hesitate to consult the article in Sciences & Vie n°1271 by Kheira Bettayeb 📖
#nasalvaccines
We are very proud and honored to inform you that Isabelle Dimier-Poisson has been conferred the"Chevalier de la Légion d'Honneur" award by the French Prime Minister, Elisabeth Borne.
#nomination #innovation #vaccine #lovaltech #research
LoValTech retweeted
✅€8.4M to develop a nasal #vaccine against #COVID19
The #startup @LoValTechFR & @aptar Pharma are winners of the French government investment plan #France2030 👏
#innovation using an INRAE & @UnivTours patent ⤵️
@EUScienceInnov @WHO
LoValTech retweeted
👏@LoValTechFR & @aptar Pharma sont lauréats #France2030 et recevront un financement de 8.4M€ pour développer un #vaccin contre le #Covid par voie nasale
🤝La #startup s'appuie sur un brevet INRAE & @UnivTours #InoverAvecINRAE
@SGPI_avenir @Bpifrance
➡️url.inrae.fr/3KnShZx
LoValTech and @aptar Pharma partnership wins #france2030 program by responding to the i-Demo collaborative project call for the MUCOVAC 2.0 project, supported as part of the "Emerging Infectious Diseases and CBRN Threats" Acceleration Strategy.
#biotech #vaccine #France2030
Thanks to the support of #france2030 steered by @BrunoBonnellOff and @GeraldineLeveau of the @SGPI_avenir and @Bpifrance, LoValTech and Aptar Pharma will be able to offer the world's population next-generation "made in France" vaccines! 🌍
#biotech #vaccine #lovaltech #France2030
Une nouvelle nomination pour Isabelle !
Nous sommes très fiers 😌
This Post is from an account that no longer exists. Learn more
Merci à @VivaTech pour cette superbe organisation et merci à la @RCValdeLoire pour cette incroyable opportunité 👏🏻
#Vivatechn2023 #startup #innovation #healthtech #HTD2023
It's an eventful week ahead for the Lovaltech team! 🦾
🇨🇭Part of the team will be in Geneva at the @ConnectinPharma event. LoValTech will be giving a talk on 14 June at 11.30am on the following topic:
Challenges and opportunities of a mucosal platform for nasal vaccination
🇫🇷 In the mean time, on 14 and 15 June, the other part of the team will be present at the @VivaTech event in Paris to represent companies from the @RCValdeLoire, thanks to the support of @Devup_ 🤝
Thank you for following and supporting everything we undertake, and please, come and meet with us during these events 😉
#healthtech #startup #vivatech2023 #HTD2023 #connectinpharma2023